Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Vascular Endothelial Activation in Obstructive Sleep Apnea
NCT03122639Phase 1Completed
- Sponsor
- Columbia University
- Start
- Sep 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in obstructive sleep apnea (OSA) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Change in proportion of CD59 on the endothelial cell surface at 28 days. Started Sep 2017; status: completed.
02
Drugs
atorvastatin
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03122639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03122639.